Cargando…

Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach

BACKGROUND: MHC class II proteins bind oligopeptide fragments derived from proteolysis of pathogen antigens, presenting them at the cell surface for recognition by CD4+ T cells. Human MHC class II alleles are grouped into three loci: HLA-DP, HLA-DQ and HLA-DR. In contrast to HLA-DR and HLA-DQ, HLA-D...

Descripción completa

Detalles Bibliográficos
Autores principales: Patronov, Atanas, Dimitrov, Ivan, Flower, Darren R, Doytchinova, Irini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146810/
https://www.ncbi.nlm.nih.gov/pubmed/21752305
http://dx.doi.org/10.1186/1472-6807-11-32
_version_ 1782209239740055552
author Patronov, Atanas
Dimitrov, Ivan
Flower, Darren R
Doytchinova, Irini
author_facet Patronov, Atanas
Dimitrov, Ivan
Flower, Darren R
Doytchinova, Irini
author_sort Patronov, Atanas
collection PubMed
description BACKGROUND: MHC class II proteins bind oligopeptide fragments derived from proteolysis of pathogen antigens, presenting them at the cell surface for recognition by CD4+ T cells. Human MHC class II alleles are grouped into three loci: HLA-DP, HLA-DQ and HLA-DR. In contrast to HLA-DR and HLA-DQ, HLA-DP proteins have not been studied extensively, as they have been viewed as less important in immune responses than DRs and DQs. However, it is now known that HLA-DP alleles are associated with many autoimmune diseases. Quite recently, the X-ray structure of the HLA-DP2 molecule (DPA*0103, DPB1*0201) in complex with a self-peptide derived from the HLA-DR α-chain has been determined. In the present study, we applied a validated molecular docking protocol to a library of 247 modelled peptide-DP2 complexes, seeking to assess the contribution made by each of the 20 naturally occurred amino acids at each of the nine binding core peptide positions and the four flanking residues (two on both sides). RESULTS: The free binding energies (FBEs) derived from the docking experiments were normalized on a position-dependent (npp) and on an overall basis (nap), and two docking score-based quantitative matrices (DS-QMs) were derived: QMnpp and QMnap. They reveal the amino acid preferences at each of the 13 positions considered in the study. Apart from the leading role of anchor positions p1 and p6, the binding to HLA-DP2 depends on the preferences at p2. No effect of the flanking residues was found on the peptide binding predictions to DP2, although all four of them show strong preferences for particular amino acids. The predictive ability of the DS-QMs was tested using a set of 457 known binders to HLA-DP2, originating from 24 proteins. The sensitivities of the predictions at five different thresholds (5%, 10%, 15%, 20% and 25%) were calculated and compared to the predictions made by the NetMHCII and IEDB servers. Analysis of the DS-QMs indicated an improvement in performance. Additionally, DS-QMs identified the binding cores of several known DP2 binders. CONCLUSIONS: The molecular docking protocol, as applied to a combinatorial library of peptides, models the peptide-HLA-DP2 protein interaction effectively, generating reliable predictions in a quantitative assessment. The method is structure-based and does not require extensive experimental sequence-based data. Thus, it is universal and can be applied to model any peptide - protein interaction.
format Online
Article
Text
id pubmed-3146810
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31468102011-07-31 Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach Patronov, Atanas Dimitrov, Ivan Flower, Darren R Doytchinova, Irini BMC Struct Biol Methodology Article BACKGROUND: MHC class II proteins bind oligopeptide fragments derived from proteolysis of pathogen antigens, presenting them at the cell surface for recognition by CD4+ T cells. Human MHC class II alleles are grouped into three loci: HLA-DP, HLA-DQ and HLA-DR. In contrast to HLA-DR and HLA-DQ, HLA-DP proteins have not been studied extensively, as they have been viewed as less important in immune responses than DRs and DQs. However, it is now known that HLA-DP alleles are associated with many autoimmune diseases. Quite recently, the X-ray structure of the HLA-DP2 molecule (DPA*0103, DPB1*0201) in complex with a self-peptide derived from the HLA-DR α-chain has been determined. In the present study, we applied a validated molecular docking protocol to a library of 247 modelled peptide-DP2 complexes, seeking to assess the contribution made by each of the 20 naturally occurred amino acids at each of the nine binding core peptide positions and the four flanking residues (two on both sides). RESULTS: The free binding energies (FBEs) derived from the docking experiments were normalized on a position-dependent (npp) and on an overall basis (nap), and two docking score-based quantitative matrices (DS-QMs) were derived: QMnpp and QMnap. They reveal the amino acid preferences at each of the 13 positions considered in the study. Apart from the leading role of anchor positions p1 and p6, the binding to HLA-DP2 depends on the preferences at p2. No effect of the flanking residues was found on the peptide binding predictions to DP2, although all four of them show strong preferences for particular amino acids. The predictive ability of the DS-QMs was tested using a set of 457 known binders to HLA-DP2, originating from 24 proteins. The sensitivities of the predictions at five different thresholds (5%, 10%, 15%, 20% and 25%) were calculated and compared to the predictions made by the NetMHCII and IEDB servers. Analysis of the DS-QMs indicated an improvement in performance. Additionally, DS-QMs identified the binding cores of several known DP2 binders. CONCLUSIONS: The molecular docking protocol, as applied to a combinatorial library of peptides, models the peptide-HLA-DP2 protein interaction effectively, generating reliable predictions in a quantitative assessment. The method is structure-based and does not require extensive experimental sequence-based data. Thus, it is universal and can be applied to model any peptide - protein interaction. BioMed Central 2011-07-14 /pmc/articles/PMC3146810/ /pubmed/21752305 http://dx.doi.org/10.1186/1472-6807-11-32 Text en Copyright ©2011 Patronov et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Patronov, Atanas
Dimitrov, Ivan
Flower, Darren R
Doytchinova, Irini
Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach
title Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach
title_full Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach
title_fullStr Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach
title_full_unstemmed Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach
title_short Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach
title_sort peptide binding prediction for the human class ii mhc allele hla-dp2: a molecular docking approach
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146810/
https://www.ncbi.nlm.nih.gov/pubmed/21752305
http://dx.doi.org/10.1186/1472-6807-11-32
work_keys_str_mv AT patronovatanas peptidebindingpredictionforthehumanclassiimhcallelehladp2amoleculardockingapproach
AT dimitrovivan peptidebindingpredictionforthehumanclassiimhcallelehladp2amoleculardockingapproach
AT flowerdarrenr peptidebindingpredictionforthehumanclassiimhcallelehladp2amoleculardockingapproach
AT doytchinovairini peptidebindingpredictionforthehumanclassiimhcallelehladp2amoleculardockingapproach